Journal of Neurology

, Volume 258, Issue 3, pp 421–426 | Cite as

Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson’s disease? An analysis using the 13C-acetate breath test

  • Yuji Tanaka
  • Tomohiro Kato
  • Hiroshi Nishida
  • Megumi Yamada
  • Akihiro Koumura
  • Takeo Sakurai
  • Yuichi Hayashi
  • Akio Kimura
  • Isao Hozumi
  • Hiroshi Araki
  • Masahiko Murase
  • Masahito Nagaki
  • Hisataka Moriwaki
  • Takashi Inuzuka
Original Communication

Abstract

During the pre-symptomatic stage of Parkinson’s disease (PD), the idiopathic PD related abnormal synuclein immunostaining is confined to the medulla oblongata and olfactory bulb, according to Braak. In the study of the enteric nervous system of PD, it has reported that Lewy bodies were found in the Auerbach’s and Meissner’s plexuses. These lesions may cause dysfunction of the gastrointestinal tract (GI) as pre-clinical symptoms of PD. However, because l-dopa therapy itself may worsen the symptoms of the digestive tract function, it is needed to evaluate the gastrointestinal tract function in patients with early-stage, untreated (de novo) PD. In the present study, using the 13C-acetate breath test (13C-ABT), we investigated gastric emptying in 20 untreated, early-stage PD patients and 40 treated, advanced-stage PD patients, and 20 healthy volunteers. Gastric emptying was examined by the 13C-ABT [the half emptying time (HET), the peak time of the 13C% dose-excess curve (Tmax)]. The Tmax and HET of gastric emptying as assessed using the 13C-ABT was significantly delayed in untreated, early-stage PD patients as compared to the controls (P < 0.001). The Tmax and HET of gastric emptying were not significantly delayed in untreated, early-stage PD patients as compared to treated, advanced-stage PD patients. The results demonstrated that delay in gastric emptying did not differ between untreated, early-stage and treated, advanced-stage PD patients. Gastric emptying of untreated, early-stage PD is already delayed. Delayed gastric emptying may be one of markers of the pre-clinical stage of PD.

Keywords

Parkinson’s disease Gastric emptying Untreated (de novo) early-stage 13C-acetate breath test 

References

  1. 1.
    Djaldetti R, Baron J, Ziv I, Melamed E (1996) Gastric emptying in Parkinson’s disease: patients with and without response fluctuation. Neurology 46:1051–1054PubMedGoogle Scholar
  2. 2.
    Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S, Honigman S, Giladi N (2001) Gastric emptying time and gastric motility in patients with Parkinson’s disease. Mov Disord 16:1041–1047PubMedCrossRefGoogle Scholar
  3. 3.
    Soykan I, Sarosiek I, Shifflett J, Wooten GF, McCallum RW (1997) Effects of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson’s disease. Mov Disord 12:952–957PubMedCrossRefGoogle Scholar
  4. 4.
    Djaldetti R, Koren M, Ziv I, Achiron A, Melamed E (1995) Effect of cisapride on response fluctuations in Parkinson’s disease. Mov Disord 10:81–84PubMedCrossRefGoogle Scholar
  5. 5.
    Tanaka Y, Kato T, Nishida H, Araki H, Murase M, Nagaki M, Moriwaki H, Inuzuka T (2009) Is there a difference in gastric emptying between Parkinson’s disease patients under long-term l-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test. J Neurol 256:1972–1976CrossRefGoogle Scholar
  6. 6.
    Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1–III/5Google Scholar
  7. 7.
    Jost WH (2009) Gastrointestinal dysfunction in Parkinson’s disease. J Neurol Sci 289:69–73PubMedCrossRefGoogle Scholar
  8. 8.
    Bramble MG, Cunliffe J, Dellipiani AW (1978) Evidence for a change in neurotransmitter affecting oesophageal motility in Parkinson’s disease. J Neurol Neurosurg Psychiatry 41:709–712PubMedCrossRefGoogle Scholar
  9. 9.
    Kurlan R, Nutt JG, Woodward WR, Rothfield K, Lichter D, Miller C, Carter JH, Shoulson I (1988) Duodenal and gastric delivery of levodopa in parkinsonism. Ann Neurol 23:589–595PubMedCrossRefGoogle Scholar
  10. 10.
    Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, Vantrappen G (1993) Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 104:1640–1647PubMedGoogle Scholar
  11. 11.
    Braden B, Adams S, Duan LP, Orth KH, Maul FD, Lembcke B, Hör G, Caspary WF (1995) The 13C-acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology 108:1048–1055PubMedCrossRefGoogle Scholar
  12. 12.
    Goetze O, Nikodem AB, Wiezcorek J, Banasch M, Przuntek H, Mueller T, Schmidt WE, Woitalla D (2006) Predictors of gastric emptying in Parkinson’s disease. Neurogastroenterol Motil 18:369–375PubMedCrossRefGoogle Scholar
  13. 13.
    Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752PubMedCrossRefGoogle Scholar
  14. 14.
    Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRefGoogle Scholar
  15. 15.
    Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease, vol II. Macmillan Healthcare Information, Florham Park, pp 153–163, 293–304Google Scholar
  16. 16.
    Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMedGoogle Scholar
  17. 17.
    Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, Komoto K, Tanaka S, Kajiyama G (1998) Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 93:1090–1096PubMedCrossRefGoogle Scholar
  18. 18.
    Medow MS, Stewart JM, Sanyal S, Mumtaz A, Sica D, Frishman WH (2008) Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope. Cardiol Rev 16:4–20PubMedCrossRefGoogle Scholar
  19. 19.
    Kuroiwa Y, Wada T, Tohgi H (1987) Measurement of blood pressure and heart-rate variation while resting supine and standing for the evaluation of autonomic dysfunction. J Neurol 235:65–68PubMedCrossRefGoogle Scholar
  20. 20.
    Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 67:189–194PubMedCrossRefGoogle Scholar
  21. 21.
    Gatti C, di Abriola FF, Dall’Oglio L, Villa M, Franchini F, Amarri S (2000) Is the 13C-acetate breath test a valid procedure to analyse gastric emptying in children? J Pediatr Surg 35:62–65PubMedCrossRefGoogle Scholar
  22. 22.
    Gonza´lez A, Mugueta C, Parra D, Labayen I, Martinez A, Varo N, Monreal I, Gil MJ (2000) Characterisation with stable isotopes of the presence of a lag phase in the gastric emptying of liquids. Eur J Nutr 39:224–228CrossRefGoogle Scholar
  23. 23.
    Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses. Acta Neuropathol 76:217–221PubMedCrossRefGoogle Scholar
  24. 24.
    Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396:67–72PubMedCrossRefGoogle Scholar
  25. 25.
    Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ (1987) Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37:1253–1255PubMedGoogle Scholar
  26. 26.
    Calne DB, Brennan J, Spiers AS, Stern GM (1970) Hypotension caused by l-dopa. Br Med J 1:474–475PubMedCrossRefGoogle Scholar
  27. 27.
    Caplan LH, Jacobson HG, Rubinstein BM, Rotman MZ (1965) Megacolon and volvulus in Parkinson’s disease. Radiology 85:73–78PubMedGoogle Scholar
  28. 28.
    Edwards LL, Pfeiffer RF, Quigley EMM, Hofman R, Balluff M (1991) Gastrointestinal symptoms in Parkinson’s disease. Mov Disord 6:151–156PubMedCrossRefGoogle Scholar
  29. 29.
    Klaue R (1940) Parkinsonsche Krankheit (Paralysis agitans) und postencephalitischer Parkinsonismus. Archiv für Psychiatrie 111:251–321CrossRefGoogle Scholar
  30. 30.
    Kuroiwa Y, Shimada Y, Toyokura Y (1983) Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology 33:463–467PubMedGoogle Scholar
  31. 31.
    Parkinson J (1817) An essay on the shaking palsy. Sherwood, Neely, and Jones, London, pp 1–66Google Scholar
  32. 32.
    Turkka JT, Juujärvi KK, Lapinlampi TO, Myllylä VV (1986) Serum noradrenaline response to standing up in patients with Parkinson’s disease. Eur Neurol 25:355–361PubMedCrossRefGoogle Scholar
  33. 33.
    Korczyn AD (1990) Autonomic nervous system disturbances in Parkinson’s disease. Adv Neurol 53:463–468PubMedGoogle Scholar
  34. 34.
    Sakakibara R, Shinotoh H, Uchiyama T, Sakuma M, Kashiwado M, Yoshiyama M, Hattori T (2001) Questionnaire-based assessment of pelvic organ dysfunction in Parkinson’s disease. Auton Neurosci 92:76–85PubMedCrossRefGoogle Scholar
  35. 35.
    Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the risk of Parkinson’s disease. Neurology 57:456–462PubMedGoogle Scholar
  36. 36.
    Wolters ECh, Braak H (2006) Parkinson’s disease: premotor clinico-pathological correlations. J Neural Transm Suppl 70:309–319PubMedCrossRefGoogle Scholar
  37. 37.
    Cersosimo MG, Benarroch EE (2008) Neural control of the gastrointestinal system: implications for Parkinson’s disease. Mov Disord 23:1065–1075PubMedCrossRefGoogle Scholar
  38. 38.
    Edwards LL, Quigley EM, Pfeiffer RF (1992) Gastrointestinal dysfunction in Parkinson’s disease: frequency and pathophysiology. Neurology 42:726–732PubMedGoogle Scholar
  39. 39.
    Jost WH (1997) Gastrointestinal motility problems in patients with Parkinson’s disease. Effects of antiparkinsonian treatment and guidelines for management. Drugs Aging 10:249–258PubMedCrossRefGoogle Scholar
  40. 40.
    Lanfranchi GA, Marzio L, Cortini C (1977) Effect of dopamine in gastric motility in man: evidence for specific receptors. In: Duthie HL (ed) Gastrointestinal motility in health and disease. MTP Publishers, Lancaster, pp 161–172Google Scholar
  41. 41.
    Urbain JL, Charkes ND (1995) Recent advances in gastric emptying scintigraphy. Semin Nucl Med 25:318–325PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Yuji Tanaka
    • 1
    • 2
  • Tomohiro Kato
    • 2
  • Hiroshi Nishida
    • 1
    • 2
  • Megumi Yamada
    • 1
  • Akihiro Koumura
    • 1
  • Takeo Sakurai
    • 1
  • Yuichi Hayashi
    • 1
  • Akio Kimura
    • 1
  • Isao Hozumi
    • 1
  • Hiroshi Araki
    • 2
  • Masahiko Murase
    • 2
  • Masahito Nagaki
    • 2
  • Hisataka Moriwaki
    • 2
  • Takashi Inuzuka
    • 1
  1. 1.Department of Neurology and Geriatrics, Graduate School of MedicineGifu UniversityGifu CityJapan
  2. 2.First Department of Internal Medicine, Graduate School of MedicineGifu UniversityGifu CityJapan

Personalised recommendations